Evergreen Theragnostics is a contract development and manufacturing platform that provides radiopharmaceutical development services.
Evergreen Theragnostics has raised $26.0M in total funding. The most recent round was Series C. The last funding was announced in April 2024.
Evergreen Theragnostics's investors include Petrichor Healthcare Capital Management, LIFTT, Club degli Investitori.
Evergreen Theragnostics is headquartered in Jersey City, United States.
Evergreen Theragnostics is a contract development and manufacturing platform that provides radiopharmaceutical development services.
Evergreen Theragnostics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Evergreen Theragnostics — Funding & Investors." VCBacked, April 16, 2024, https://www.vcbacked.co/company/evergreen-theragnostics. Accessed October 28, 2026.
VCBacked. (2024). Evergreen Theragnostics — Funding & Investors. Retrieved October 28, 2026, from https://www.vcbacked.co/company/evergreen-theragnostics
{{cite web |title=Evergreen Theragnostics — Funding & Investors |url=https://www.vcbacked.co/company/evergreen-theragnostics |website=VCBacked |access-date=October 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated